- Home
- PCRX vs NGL Comparison
PCRX vs NGL Comparison
Compare PCRX & NGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- NGL
- Stock Information
- Founded
- PCRX 2006
- NGL 1940
- Country
- PCRX United States
- NGL United States
- Employees
- PCRX N/A
- NGL N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- NGL Natural Gas Distribution
- Sector
- PCRX Health Care
- NGL Utilities
- Exchange
- PCRX Nasdaq
- NGL Nasdaq
- Market Cap
- PCRX 604.7M
- NGL 564.5M
- IPO Year
- PCRX 2011
- NGL 2011
- Fundamental
- Price
- PCRX $16.52
- NGL $4.30
- Analyst Decision
- PCRX Buy
- NGL
- Analyst Count
- PCRX 10
- NGL 0
- Target Price
- PCRX $26.60
- NGL N/A
- AVG Volume (30 Days)
- PCRX 545.3K
- NGL 255.3K
- Earning Date
- PCRX 11-06-2024
- NGL 11-12-2024
- Dividend Yield
- PCRX N/A
- NGL N/A
- EPS Growth
- PCRX N/A
- NGL N/A
- EPS
- PCRX N/A
- NGL N/A
- Revenue
- PCRX $694,957,000.00
- NGL $6,239,231,000.00
- Revenue This Year
- PCRX $4.59
- NGL N/A
- Revenue Next Year
- PCRX N/A
- NGL $3.50
- P/E Ratio
- PCRX N/A
- NGL N/A
- Revenue Growth
- PCRX 4.40
- NGL N/A
- 52 Week Low
- PCRX $11.16
- NGL $3.84
- 52 Week High
- PCRX $35.95
- NGL $6.20
- Technical
- Relative Strength Index (RSI)
- PCRX 44.28
- NGL 51.74
- Support Level
- PCRX $16.11
- NGL $3.84
- Resistance Level
- PCRX $18.34
- NGL $4.53
- Average True Range (ATR)
- PCRX 0.83
- NGL 0.20
- MACD
- PCRX -0.17
- NGL 0.04
- Stochastic Oscillator
- PCRX 5.33
- NGL 66.67
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, and for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.